Back to Browse Journals » International Journal of Nanomedicine » Volume 7
Increased brain radioactivity by intranasal 32P-labeled siRNA dendriplexes within in situ-forming mucoadhesive gels
Authors Perez AP, Mundiña-Weilenmann C, Romero EL, Morilla MJ
Received 15 November 2011
Accepted for publication 5 January 2012
Published 12 March 2012 Volume 2012:7 Pages 1373—1385
DOI https://doi.org/10.2147/IJN.S28261
Review by Single-blind
Peer reviewer comments 4
Ana Paula Perez1, Cecilia Mundiña-Weilenmann2, Eder Lilia Romero1, Maria Jose Morilla1
1Programa de Nanomedicinas, Departamento de Ciencia y Tecnología, Universidad Nacional de Quilmes, Buenos Aires, 2Centro de Investigaciones Cardiovasculares, CCT-La Plata, CONICET, Facultad de Ciencias Médicas, Universidad Nacional de La Plata, La Plata, Argentina
Background: Molecules taken up by olfactory and trigeminal nerve neurons directly access the brain by the nose-to-brain pathway. In situ-forming mucoadhesive gels would increase the residence time of intranasal material, favoring the nose-to-brain delivery. In this first approach, brain radioactivity after intranasal administration of 32P-small interference RNA (siRNA) complexed with poly(amidoamine) G7 dendrimers (siRNA dendriplexes) within in situ-forming mucoadhesive gels, was determined.
Materials: 32P-siRNA dendriplexes were incorporated into in situ-forming mucoadhesive gels prepared by blending thermosensitive poloxamer (23% w/w) with mucoadhesive chitosan (1% w/w, PxChi) or carbopol (0.25% w/w, PxBCP). Rheological properties, radiolabel release profile, and local toxicity in rat nasal mucosa were determined. The best-suited formulation was intranasally administered to rats, and blood absorption and brain distribution of radioactivity were measured.
Results: The gelation temperature of both formulations was 23°C. The PxChi liquid showed non-Newtonian pseudoplastic behavior of high consistency and difficult manipulation, and the gel retained 100% of radiolabel after 150 minutes. The PxCBP liquid showed a Newtonian behavior of low viscosity and easy manipulation, while in the gel phase showed apparent viscosity similar to that of the mucus but higher than that of aqueous solution. The gel released 35% of radiolabel and the released material showed silencing activity in vitro. Three intranasal doses of dendriplexes in PxCBP gel did not damage the rat nasal mucosa. A combination of 32P-siRNA complexation with dendrimers, incorporation of the dendriplexes into PxCBP gel, and administration of two intranasal doses was necessary to achieve higher brain radioactivity than that achieved by intravenous dendriplexes or intranasal naked siRNA.
Conclusion: The increased radioactivity within the olfactory bulb suggested that the combination above mentioned favored the mediation of a direct brain delivery.
Keywords: nucleic acids, gel, dendrimers, mucosa, olfactory bulb
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.
Other articles by this author:
Selective cytotoxicity of PAMAM G5 core–PAMAM G2.5 shell tecto-dendrimers on melanoma cells
Schilrreff P, Mundiña-Weilenmann C, Romero EL, Morilla MJ
International Journal of Nanomedicine 2012, 7:4121-4133
Published Date: 31 July 2012
Uptake and intracellular traffic of siRNA dendriplexes in glioblastoma cells and macrophages
Perez AP, Cosaka ML, Romero EL, Morilla MJ
International Journal of Nanomedicine 2011, 6:2715-2728
Published Date: 4 November 2011
Readers of this article also read:
Use of complementary and alternative medicine before and after organ removal due to urologic cancer
Mani J, Juengel E, Arslan I, Bartsch G, Filmann N, Ackermann H, Nelson K, Haferkamp A, Engl T, Blaheta RA
Patient Preference and Adherence 2015, 9:1407-1412
Published Date: 1 October 2015
Emerging and future therapies for hemophilia
Carr ME, Tortella BJ
Journal of Blood Medicine 2015, 6:245-255
Published Date: 3 September 2015
The first clinical experience on efficacy of topical flutamide on melasma compared with topical hydroquinone: a randomized clinical trial
Adalatkhah H, Sadeghi-Bazargani H
Drug Design, Development and Therapy 2015, 9:4219-4225
Published Date: 4 August 2015
A new recombinant factor VIII: from genetics to clinical use
Santagostino E
Drug Design, Development and Therapy 2014, 8:2507-2515
Published Date: 12 December 2014
Absent activation in medial prefrontal cortex and temporoparietal junction but not superior temporal sulcus during the perception of biological motion in schizophrenia: a functional MRI study
Hashimoto N, Toyomaki A, Hirai M, Miyamoto T, Narita H, Okubo R, Kusumi I
Neuropsychiatric Disease and Treatment 2014, 10:2221-2230
Published Date: 17 November 2014
Purification and in vitro antioxidant activities of tellurium-containing phycobiliproteins from tellurium-enriched Spirulina platensis
Yang F, Wong KH, Yang YF, Li XL, Jiang J, Zheng WJ, Wu HL, Chen TF
Drug Design, Development and Therapy 2014, 8:1789-1800
Published Date: 9 October 2014
Sensory disturbances, inhibitory deficits, and the P50 wave in schizophrenia
Vlcek P, Bob P, Raboch J
Neuropsychiatric Disease and Treatment 2014, 10:1309-1315
Published Date: 14 July 2014
Non-adherence to topical treatments for actinic keratosis
Shergill B, Zokaie S, Carr AJ
Patient Preference and Adherence 2014, 8:35-41
Published Date: 17 December 2013
Manipulation of magnetic nanoparticle retention and hemodynamic consequences in microcirculation: assessment by laser speckle imaging
Ma YH, Chen SY, Tu SJ, Yang HW, Liu HL
International Journal of Nanomedicine 2012, 7:2817-2827
Published Date: 11 June 2012
The role of transdermal estrogen sprays and estradiol topical emulsion in the management of menopause-associated vasomotor symptoms
Amy M Egras, Elena M Umland
International Journal of General Medicine 2010, 3:147-151
Published Date: 10 May 2010
